Form 4: Saba Capital Management Sells Shares in BlackRock Capital Allocation Term Trust

Saba Capital Management, a 10% owner of BlackRock Capital Allocation Term Trust, disposed of 311,729 shares of common stock on April 30, 2025.

Summary

• On April 30, 2025, Saba Capital Management, L.P. sold 311,729 shares of BlackRock Capital Allocation Term Trust (BCAT) common stock.
• The shares were sold at a price of $14.39 per share.
• Following the transaction, Saba Capital Management, L.P. indirectly owns 11,481,139 shares of BCAT.
• Boaz Weinstein, also a reporting person, is associated with this transaction.

Sentiment

Score: 5

Explanation: Neutral sentiment as it simply reports a transaction. The sale itself could be interpreted in various ways, but the document provides no further context.

Negatives

• Saba Capital Management reduced its holdings in BlackRock Capital Allocation Term Trust.

Risks

• Further sales by Saba Capital Management could put downward pressure on the stock price.

Industry Context

Hedge funds like Saba Capital Management frequently adjust their holdings in response to market conditions and investment strategies. This sale could reflect a change in Saba's outlook for BCAT or a reallocation of capital to other opportunities.

Comparison to Industry Standards

• It's common for large shareholders like Saba Capital to periodically adjust their positions in closed-end funds.
• Other activist investors, such as Bulldog Investors, also actively manage their holdings in similar investment vehicles.
• Comparing Saba's trading activity to that of other major shareholders in BCAT and similar funds could provide further context.

Stakeholder Impact

• The sale of shares could potentially impact the share price of BlackRock Capital Allocation Term Trust, affecting shareholders.
• The impact on other stakeholders is likely to be minimal.

Key Dates

Keywords

Saba Capital Management, BlackRock Capital Allocation Term Trust, BCAT, share disposal, Form 4, Boaz Weinstein, ownership